Physician profile
Ethan Handler
NPI 1831359801
$2,871.70
in general payments reported to CMS, 2019-2025
9 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $1,038 · 2021: $974 · 2022: $354 · 2023: $116 · 2024: $69.02 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.97 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $874.12 | 2019-2023 | Xpress Ent Dilation System |
| Aerin Medical INC. | $865.85 | 2019-2024 | |
| Optinose US, INC. | $387.95 | 2021-2023 | |
| Medtronic, INC. | $262.59 | 2023-2025 | Propel, Merocel |
| Intersect Ent, INC. | $201.64 | 2021 | |
| Inspire Medical Systems, INC. | $121.85 | 2021 | |
| Medtronic USA, INC. | $114.55 | 2020 | |
| Integra Lifesciences Corporation | $25.15 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Baxter Healthcare | $18.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.